Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2)
BMJ open, 2026;16(8):e120427
Semaglutide vs Metabolic and Bariatric Surgery and Cardiovascular Outcomes in Obesity
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
EQ-5D Health Utility Gains with Once-Weekly Semaglutide 2.4 mg in People with MASH and F2/F3 Fibrosis: An Analysis of ESSENCE
JHEP reports : innovation in hepatology, 2026;:101993
Semaglutide/Acarbose combination protects against diabetic nephropathy in rats; a novel insight into modulation of Nrf-2/HO-1& TGF-β/Smad pathways
International immunopharmacology, 2026;187:117277
Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review
Cureus, 2026;18(8):e114350
Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI);32(8):e70360
A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health
CPT: pharmacometrics & systems pharmacology;15(8):e70322
Superior Cardiorenal Protection With Tirzepatide Over Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Large-Scale Propensity Score-Matched Real-World Analysis
Clinical cardiology;49(8):e70441
Perioperative management of GLP-1 receptor agonists: a structured narrative review with considerations relevant to neurosurgical patients
Journal of endocrinological investigation, 2026
Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities
Molecular biology reports, 2026;53(1)
Tirzepatide Use Is Associated with Reduced Risk of Carpal Tunnel Syndrome in Overweight and Obese Adults
Clinical pharmacology and therapeutics, 2026
Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity
European journal of preventive cardiology, 2026
GLP-1-Based Therapies in Pain Medicine: A Narrative Review and Expert Opinion on Obesity-Related Low Back and Knee Pain
Current pain and headache reports, 2026;30(1)
Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis
Journal of pediatric endocrinology & metabolism : JPEM, 2026
Prescribed but Not Filled: Patient Factors Related to Semaglutide/Tirzepatide Prescription Fills Among Those With Prescription Orders for Obesity Treatment
Diabetes, obesity & metabolism, 2026
AI Patient Support and 6-Month Medication Adherence in a Digital Obesity Program: A Retrospective Analysis
Diabetes, obesity & metabolism, 2026
Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6-Month Claims Database Analysis
Diabetes, obesity & metabolism, 2026
Changes in recorded background glucose-lowering therapy after initiation of a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist in adults with type 2 diabetes
Diabetes research and clinical practice, 2026;:113493
First Approval of Semaglutide for MASH in India: A Paradigm Shift in MASLD Management?
Drug discovery today, 2026;:104762
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
The lancet. Diabetes & endocrinology, 2026